InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
T+90 hit rate
40%
T+90 mean return
-2.0%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by REUVERS DANIEL L., Chairman & CEO. Insider active across 1 company, notably Tactile Systems Technology INC. Cumulatively, 15 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €882k. History available since 7 July 2021. The latest transaction was disclosed on 11 March 2025 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations15 total
68,162 shares0Common StockSEC:0001437749-25-007530:0
28,338 shares@ US$14.180643.6% of flowCommon StockSEC:0001437749-25-005481:0
15,853 shares0Common StockSEC:0001437749-25-004938:0
4,689 shares@ US$15.607.6% of flowCommon StockSEC:0001437749-24-006205:0
5,378 shares@ US$14.8488.4% of flowCommon StockSEC:0001437749-24-005784:0
72,046 shares0Common StockSEC:0001437749-24-005438:0
1,062 shares@ US$20.53452.2% of flowCommon StockSEC:0001437749-23-022794:0
6,482 shares0Common StockSEC:0001437749-23-004978:0
52,613 shares0Common StockSEC:0001437749-23-004565:0
1,020 shares@ US$9.18011.0% of flowCommon StockSEC:0001437749-22-019830:0
53,937 shares0Common StockSEC:0001437749-22-004756:0
1,063 shares@ US$43.11210.0060% mcap11.8% of flowCommon StockSEC:0001437749-21-019032:0
1,063 shares@ US$43.11214.4% of flowCommon StockSEC:0001437749-21-019032
2,961 shares@ US$49.753414.2% of flowCommon StockSEC:0001437749-21-016567
2,961 shares@ US$49.75340.019% mcap38.2% of flowCommon StockSEC:0001437749-21-016567:0
15 of 15 declarations
About REUVERS DANIEL L.
Reuvers Daniel L. is President and Chief Executive Officer of Tactile Systems Technology Inc. He oversees the company's operations and plays a key role in strategic development. Daniel is committed to promoting innovation and improving operational efficiency to meet customer needs in the medical technology sector.
